
In continuing coverage, the St. Louis Post-Dispatch reports that the Food and Drug Administration “has reclassified surgical mesh used to repair pelvic organ prolapse as ‘high risk,’ citing thousands of reports of complications involving its use.” Manufacturers will be required to “complete a rigorous application process demonstrating the safety and effectiveness of the implant.”
From the news release of the American Association for Justice.